DNA methylation and chromatin dynamics during postnatal cardiomyocyte maturation

Abstract

Background: The neonatal mammalian heart has a transient capacity for regeneration, which is lost shortly after birth. A series of critical developmental transitions including a switch from hyperplastic to hypertrophic growth occur during this postnatal regenerative window, preparing the heart for the increased contractile demands of postnatal life. Postnatal cardiomyocyte maturation and loss of regenerative capacity are associated with expression alterations of thousands of genes embedded within tightly controlled transcriptional networks, which remain poorly understood. Interestingly, although mitogenic stimulation of neonatal cardiomyocytes results in proliferation, the same stimuli induce hypertrophy in adult cardiomyocytes by activating different transcriptional pathways, indicating that cardiomyocyte maturation may result from epigenetic modifications during development. Notably, DNA methylation and chromatin compaction are both important epigenetic modifications associated with a decrease in transcription factor (TF) accessibility to DNA. However, the role of both DNA methylation and chromatin compaction during postnatal cardiac maturation remain largely unknown.Hypothesis: Postnatal changes in DNA methylation and chromatin compaction silence transcriptional networks required for cardiomyocyte proliferation during postnatal heart development.Aims: This PhD Thesis focuses on characterising the role of DNA methylation and chromatin dynamics during postnatal cardiac development and maturation using in vitro and in vivo model systems. Three major Aims are addressed:• Aim 1: To characterize transcription and DNA methylation dynamics during postnatal rodent cardiac development (Chapter 3).• Aim 2: To determine the role of DNA methylation in regulating the expression of cell cycle related genes in mouse and human cardiomyocytes (Chapter 4).• Aim 3: To understand the relationship between chromatin accessibility and transcription during mouse and human cardiomyocyte development (Chapter 5).Results: In Aim 1, global DNA methylation changes were characterized during postnatal development. Marked changes in the expression levels of key DNA methylation enzymes were observed during the first month of postnatal heart development. Postnatal inhibition of DNA methylation using 5-aza-2’-deoxycytidine (5aza-dC; 1mg/kg/day) reduced global DNA methylation levels in the heart in vivo and was associated with a marked increase in cardiomyocyte proliferation (~3-fold) and ~50% reduction in binucleated cardiomyocytes compared to saline-treated controls, suggesting DNA methylation is required for postnatal cardiomyocyte cell cycle arrest. Nextgeneration mRNA sequencing (RNA-seq) and genome-wide sequencing of methylated DNA (methyl-CpG binding domain enrichment and sequencing (MBD-seq)) identified dynamic changes in the cardiac methylome during postnatal development (2545 differentially methylated regions (DMRs) from postnatal day (P) 1 to P14 in the mouse). ~80% of DMRs were hypermethylated and these DMRs were associated with transcriptional shut down of important developmental signalling pathways.In Aim 2, a specific subset of cell cycle genes displaying differentially regulated gene expression and DNA methylation patterns were profiled to understand how DNA methylation is involved in regulating cardiomyocyte proliferation. Gene expression profiling of these cell cycle genes during development and following 5aza-dC treatment in mouse hearts, as well as 3D human cardiac organoids (hCOs), verified that DNA methylation was required for transcriptional regulation of a small group of cell cycle genes. Interestingly, 5aza-dC (10µM) also induced ~2-fold increase in cardiomyocyte proliferation in hCOs. These findings suggest that DNA methylation has a direct role in the regulation of a subset of genes required for cardiomyocyte proliferation in both mice and humans.Chromatin accessibility results from the integrated action of multiple epigenetic marks. In Aim 3, cardiomyocyte nuclei were isolated from both human and mouse developmental heart samples for RNA-seq and for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) to profile changes in transcription and chromatin accessibility during cardiomyocyte development in mice (P1 to P56) and humans (foetal (14-19 weeks (wks)), 0-10 years (yrs), 10-30 yrs and 30+ yrs). RNA-seq confirmed that cardiomyocyte cell cycle arrest occurs between P1 and P14 in the mouse. Moreover, ATAC-seq identified open chromatin signatures at various genomic features, including CG islands, transcription start sites (TSSs), enhancers, TF binding sites and protein coding regions, while intergenic regions were associated with compact chromatin. Integration of RNA-seq and ATAC-seq data demonstrated a strong correlation between transcription and chromatin accessibility at the different stages of cardiomyocyte development. TF motif analysis identified E2F transcription factor 4 (E2f4) and Forkhead box M1 (Foxm1) sites as being transcriptionally repressed and undergoing chromatin compaction from P1 to P56. E2f4 and Foxm1 are well known TFs that regulate cell cycle, thus suggesting that cell cycle genes are epigenetically silenced during cardiomyocyte maturation.Conclusion: This PhD Thesis provides novel evidence for widespread alterations in DNA methylation during postnatal heart maturation and suggests that cardiomyocyte cell cycle arrest during the neonatal period is subject to regulation by DNA methylation and chromatin compaction. Together, this PhD Thesis provides new insights into the role of DNA methylation and chromatin dynamics during cardiac development. This Thesis provides a new framework for the epigenetic regulation of transcription during postnatal cardiomyocyte maturation and points towards an epigenetic mechanism for cardiomyocyte terminal differentiation during the neonatal period.